23262373|t|Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
23262373|a|BACKGROUND: Neuromyelitis optica (NMO), which was previously considered a variant of multiple sclerosis (MS), is characterized by recurrent optic neuritis and longitudinally extensive spinal cord lesions. It has been shown that the level of haptoglobin in cerebrospinal fluid (CSF) is elevated in NMO. However, it is uncertain whether this change is specific to NMO, or is also seen in MS and other neurological diseases. METHODS: We used an enzyme-linked immunosorbent assay (ELISA) to measure the haptoglobin levels in the CSF and serum in 25 NMO, 16 MS, and 15 Alzheimer's disease (AD) patients and 22 controls. RESULTS: The CSF haptoglobin concentration of the NMO patients (0.309+-0.074mg/dl, P<0.001) was significantly higher than that of MS patients (0.081+-0.016mg/dl) and AD patients (0.058+-0.011mg/dl), and the controls (0.060+-0.009mg/dl), whereas the serum haptoglobin and albumin concentrations in the serum and CSF did not differ significantly across groups. NMO patients (0.59+-0.15, P=0.001) demonstrated a higher haptoglobin index than MS patients (0.13+-0.01), AD patients (0.12+-0.03), and the controls (0.17+-0.04). Furthermore, the haptoglobin concentration and haptoglobin index in the CSF correlated significantly with the expanded disability scale score (EDSS) in NMO patients. CONCLUSIONS: The high CSF haptoglobin concentration in NMO may be explained by increased intrathecal haptoglobin synthesis. The correlation between CSF haptoglobin concentration/haptoglobin index and EDSS highlights the potential of haptoglobin as a biomarker of NMO.
23262373	12	23	haptoglobin	Gene	3240
23262373	70	78	patients	Species	9606
23262373	84	104	neuromyelitis optica	Disease	MESH:D009471
23262373	109	127	multiple sclerosis	Disease	MESH:D009103
23262373	141	161	Neuromyelitis optica	Disease	MESH:D009471
23262373	163	166	NMO	Disease	MESH:D009471
23262373	214	232	multiple sclerosis	Disease	MESH:D009103
23262373	234	236	MS	Disease	MESH:D009103
23262373	269	283	optic neuritis	Disease	MESH:D009902
23262373	313	332	spinal cord lesions	Disease	MESH:D013118
23262373	370	381	haptoglobin	Gene	3240
23262373	426	429	NMO	Disease	MESH:D009471
23262373	491	494	NMO	Disease	MESH:D009471
23262373	515	517	MS	Disease	MESH:D009103
23262373	528	549	neurological diseases	Disease	MESH:D020271
23262373	628	639	haptoglobin	Gene	3240
23262373	674	677	NMO	Disease	MESH:D009471
23262373	682	684	MS	Disease	MESH:D009103
23262373	693	712	Alzheimer's disease	Disease	MESH:D000544
23262373	714	716	AD	Disease	MESH:D000544
23262373	718	726	patients	Species	9606
23262373	761	772	haptoglobin	Gene	3240
23262373	794	797	NMO	Disease	MESH:D009471
23262373	798	806	patients	Species	9606
23262373	874	876	MS	Disease	MESH:D009103
23262373	877	885	patients	Species	9606
23262373	910	912	AD	Disease	MESH:D000544
23262373	913	921	patients	Species	9606
23262373	999	1010	haptoglobin	Gene	3240
23262373	1015	1022	albumin	Gene	213
23262373	1103	1106	NMO	Disease	MESH:D009471
23262373	1107	1115	patients	Species	9606
23262373	1160	1171	haptoglobin	Gene	3240
23262373	1183	1185	MS	Disease	MESH:D009103
23262373	1186	1194	patients	Species	9606
23262373	1209	1211	AD	Disease	MESH:D000544
23262373	1212	1220	patients	Species	9606
23262373	1283	1294	haptoglobin	Gene	3240
23262373	1313	1324	haptoglobin	Gene	3240
23262373	1418	1421	NMO	Disease	MESH:D009471
23262373	1422	1430	patients	Species	9606
23262373	1458	1469	haptoglobin	Gene	3240
23262373	1487	1490	NMO	Disease	MESH:D009471
23262373	1533	1544	haptoglobin	Gene	3240
23262373	1584	1595	haptoglobin	Gene	3240
23262373	1610	1621	haptoglobin	Gene	3240
23262373	1665	1676	haptoglobin	Gene	3240
23262373	1695	1698	NMO	Disease	MESH:D009471
23262373	Positive_Correlation	MESH:D009471	3240

